FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/06/019823 [Registered on: 24/06/2019] Trial Registered Prospectively
Last Modified On: 18/06/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Screening 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of efficacy of Haridrakahanda and Vyoshadi vati in the treatment of Allergic Rhinitis as prophyalctic medicine  
Scientific Title of Study   Comparative Clinical trial of efficacy of Haridrakahanda and Vyoshadi vati in the management of Allergic Rhinitis as prophyalctic medicine  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Akshata kalje  
Designation  PG student  
Affiliation  Tilak Ayurved Mahavidyalaya  
Address  Seth Tarachand Ramnath Charitable Hospital girls hostel first floor room no 102 rastha peth Pune 411011

Pune
MAHARASHTRA
411011
India 
Phone  9011640493  
Fax    
Email  akshata.kalje@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Salvi Sangeeta Santosh 
Designation  HOD and Guide Shalakyatnatra  
Affiliation  Tilak Ayurved Mahavidyalaya  
Address  Tilak Ayurved Mahavidyalaya 2nd floor shalakyatantra department rastha peth pune

Pune
MAHARASHTRA
411011
India 
Phone  9822082795  
Fax    
Email  salvisangeeta@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Akshata Rajaram Kalje  
Designation  PG student  
Affiliation  Tilak Ayurved Mahavidyalaya  
Address  Seth Tarachand Ramnath Charitable Hospital girls hostel first floor room no 102 rastha peth pune

Pune
MAHARASHTRA
411011
India 
Phone  9011640493  
Fax    
Email  akshata.kalje@gmail.com  
 
Source of Monetary or Material Support  
Tilak ayurved mahavidyalaya 2nd floor Shalakyatnatra depart department rastha peth pune 411011 
 
Primary Sponsor  
Name  Tilak Ayurved Mahavidyalaya  
Address  Rastha peth pune411011 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Akshata Rajaram Kalje   Seth Tarachand Ramnath Charitable Hospital   Opd building 1st floor opd no 15 Rastha peth pune 411011
Pune
MAHARASHTRA 
9011640493

akshata.kalje@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics commitee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J309||Allergic rhinitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Haridrakhanada   Haridrakhanda prepared by awaleha kalpana.given to patienta of age between 18 to 60 dose 5gm twice a day for 30 days n follow up will taken on 15th,30th,60th and 90th day  
Comparator Agent  Vyoshadi vati   Vyoshadi vati prepared by vati kalpana given to patients of age between 18 to 60 dose 500mg twice a day for 30 days n follow up will taken on 15th 30th,60th,90th day  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient diagnosed as alleegic rhinitis
 
 
ExclusionCriteria 
Details  Patients with vasomotor rhinitis, acute infective rhinitis, atrophic rhinitis, pregnant women, lactating mother, patients suffering from malignancy, tuberculosis, systemic illness  
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To study the efficacy of Haridrakahanda and Vyoshadi vati in the management of Allergic Rhinitis as prophyalctic medicine   3 months  
 
Secondary Outcome  
Outcome  TimePoints 
To study efficacy of Haridrakahanda in management of allergic rhinitis as prophylactic medicine
To study the efficacy of vyoshadi vati in management of allergic rhinitis as prophylactic medicine
To study adverse effects of Haridrakhanada and Vyoshadi vati  
3 months  
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   24/06/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Allergic rhinitis is one of the most commonest disease found due to this changes.allergic rhinitis is well known for its recurrence.Recurrence of disease occur only when vitiated doshas have not been  eradicated completely. In allergic rhinitis principle of treatment is avoid allergens causing allergic reaction, detoxification, and prophylactic treatment to increase the immunity and to decrease Recurrence of disease. Haridrakhanada has anti allergic and antioxidant property.   
Close